Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

The 5 Worst Reasons to Buy Marijuana Stocks


The 5 Worst Reasons to Buy Marijuana Stocks

Chances are you'd struggle to find an industry that's been stronger over the trailing one-year period than legal marijuana. Cannabis research firm ArcView pegged North American legal weed growth at 34% in 2016 and foresees a compound annual growth rate of 26% over the coming five-year period.  Not surprisingly, marijuana stocks have jumped, as an aggregate, by an average of more than 100% over the trailing year, if we only consider the 14 with a current market cap above $200 million.

Aside from the massive sales growth behind pot stocks, changing public perceptions have played a key role. No longer perceived to be on the same level as heroin, LSD, and other Schedule I substances, some 60% of respondents want to see marijuana legalized across the U.S., according to Gallup's October 2016 poll. This represents an all-time record high, and it suggests that pressure could be mounting on Congress to make changes in their scheduling of cannabis at the federal level.

Image source: Getty Images.

Continue reading


Source: Fool.com

GW Pharmaceuticals plc ADR Stock

€183.00
0.550%
The GW Pharmaceuticals plc ADR stock is trending slightly upwards today, with an increase of €1.00 (0.550%) compared to yesterday's price.

Like: 0
Share

Comments